Related Experiment Video
Updated: Feb 13, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease
Heitor S P de Souza1,2, Claudio Fiocchi3,4
1Department of Gastroenterology & Multidisciplinary Research Laboratory, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Network medicine offers innovative therapies for inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). Targeting key molecular hubs in the IBD interactome can disrupt disease pathways and improve treatment outcomes.
Area of Science:
- Gastroenterology
- Immunology
- Systems Biology
Background:
- Current inflammatory bowel disease (IBD) treatments, including for Crohn's disease (CD) and ulcerative colitis (UC), show limited success due to targeting individual pathways.
- IBD is a complex condition influenced by human biological diversity and multiple, not fully understood, pathogenic factors.
Purpose of the Study:
- To propose network medicine as a novel therapeutic strategy for IBD.
- To advocate for targeting central nodes (hubs) within the IBD molecular interactome.
Main Methods:
- Conceptual framework development based on network medicine principles.
- Identification of the molecular structure of the IBD interactome.
- Strategic targeting of controlling elements within the interactome.
Main Results:
- Network medicine offers a paradigm shift from single-target therapies to systems-level intervention.
- Targeting IBD interactome hubs can disrupt disease pathways more effectively than current approaches.
Conclusions:
- Innovative therapies for IBD require bold thinking, moving beyond current limitations.
- Network medicine provides a framework for developing highly effective, targeted treatments for CD and UC by disrupting the core molecular disease network.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

